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Background: Bok is a Bcl-2 protein family 
member, with largely unknown properties. 
Results: Bok binds constitutively to IP3 receptors 
and protects them from proteolysis, but does not 
appear to alter their Ca2+ channel activity.  
Conclusion: Bok is novel component of IP3 
receptor complexes. 
Significance: A new locus for studies on IP3 
receptor and apoptosis regulation has been defined. 
 
SUMMARY 
Bok is a member of the Bcl-2 protein family 
that controls intrinsic apoptosis.  Bok is most 
closely related to the pro-apoptotic proteins Bak 
and Bax, but in contrast to Bak and Bax, very 
little is known about its cellular role.  Here we 
report that Bok binds strongly and 
constitutively to inositol 1,4,5-trisphosphate 
receptors (IP3Rs), proteins that form tetrameric 
calcium channels in the endoplasmic reticulum 
(ER) membrane and govern the release of ER 
calcium stores.  Bok binds most strongly to 
IP3R1 and IP3R2, and barely to IP3R3, and 
essentially all cellular Bok is IP3R bound in cells 
that express substantial amounts of IP3Rs.  
Binding to IP3Rs appears to be mediated by the 
putative BH4 domain of Bok and the docking 
site localizes to a small region within the 
coupling domain of IP3Rs (amino acids 1895-
1903 of IP3R1) that is adjacent to numerous 
regulatory sites, including sites for proteolysis.  
With regard to the possible role of Bok-IP3R 
binding, the following was observed: (i) Bok 
does not appear to control the ability of IP3Rs to 
release ER calcium stores, (ii) Bok regulates 
IP3R expression, (iii) persistent activation of 
inositol 1,4,5-trisphosphate-dependent cell 
signaling causes Bok degradation by the 
ubiquitin-proteasome pathway, in a manner 
that parallels IP3R degradation, and (iv) Bok 
protects IP3Rs from proteolysis, either by 
chymotrypsin in vitro or by caspase-3 in vivo 
during apoptosis.   Overall, these data show that 
Bok binds strongly and constitutively to IP3Rs 
and that the most significant consequence of 
this binding appears to be protection of IP3Rs 
from proteolysis.   Thus, Bok may govern IP3R 
cleavage and activity during apoptosis.  
 
 The Bcl-2 protein family governs the 
intrinsic (mitochondrial) apoptotic pathway, and 
contains members that are anti-apoptotic (e.g. Bcl-
2 and Mcl-1), and also members that are pro-
apoptotic (e.g. Bax and Bak); complex interactions 
between these proteins control apoptosis and cell 
viability [1,2].   These proteins contain conserved 
Bcl-2 homology (BH) domains, and it has been 
generally thought that pro-apoptotic proteins like 
Bax and Bak contain three BH domains (BH1, 
BH2 and BH3), whereas anti-apoptotic proteins 
like Bcl-2 and Mcl-1 contain four (BH1, BH2, 
BH3 and BH4), with the BH4 domain conferring 
anti-apoptotic activity [1,2].   An additional group 
of pro-apoptotic BH3-only proteins (e.g. Bim and 
Bad) completes the family [1,2].  This canonical 
view is not settled, however, as it appears that pro-
apoptotic proteins like Bax and Bak may also 
contain a BH4 domain [2,3]. 
Bax and Bak are closely related proteins 
that, when active, induce permeabilization of the 
outer mitochondrial membrane, cytochrome c 
release, caspase activation and, ultimately, 
apoptosis [1-3].  Interestingly, while knockout of 
either Bax or Bak has little effect on mouse 
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physiology (although Bax-/- males are sterile), 
Bax/Bak knockout mice exhibit various severe 
defects, indicating redundancy of function for Bax 
and Bak [1].    Bok, which was originally identified 
as an Mcl-1-binding protein, is similar in sequence 
to Bax and Bak and has the same arrangement of 
domains [4-6], but has been investigated much less 
thoroughly [1-3].  Bok is expressed in many, and 
perhaps all, mammalian cell types [7,8] and, like 
Bax and Bak [3,5,6], its over-expression in 
cultured cells causes apoptosis [4-9].  Mice lacking 
Bok are phenotypically normal and hematopoietic 
cells derived from these mice respond normally to 
apoptotic stimuli [7], again indicative of 
redundancy among the Bok/Bax/Bak group.  
However, it is important to note that the existence 
of severe defects in Bax/Bak knockout mice show 
that Bok cannot compensate for the absence of Bak 
and Bax [1], and suggest that it has unique 
properties.  Indeed, the pro-apoptotic effect of Bok 
is not seen in cells lacking Bak and Bax, indicating 
that it acts in concert with or upstream of Bak and 
Bax [8].  Further, the atypical transmembrane 
domain of Bok appears to direct it towards the 
endoplasmic reticulum (ER) and Golgi, rather than 
to the mitochondrial outer membrane, which is the 
more typical location for many other Bcl-2 family 
members [8].    How this distribution contributes to 
the cellular role of Bok remains unclear, however 
[8].  Finally, the Bok gene region is frequently 
deleted in cancer, suggesting that it might be a 
tumor suppressor [10]. 
An extensive, but confusing, literature 
exists regarding the regulation of inositol 1,4,5-
trisphosphate (IP3) receptors (IP3Rs) by Bcl-2 
family proteins [11,12].  IP3Rs are ~300kDa 
proteins that form tetrameric, IP3- and Ca2+-gated 
Ca2+ channels in ER membranes of mammalian 
cells and play a key role in cell signaling [13,14]. 
There are three highly homologous IP3R types in 
mammals, IP3R1, IP3R2 and IP3R3, and although 
their tissue distribution varies, they have similar 
properties, are often co-expressed, and form 
heteromers [13-15].    IP3, in concert with Ca2+ 
binding, induces yet to be defined conformational 
changes in the tetrameric channel that allow Ca2+ 
to flow from stores within the ER lumen into the 
cytosol to increase cytosolic Ca2+ concentration 
[13,14].  IP3Rs also play a role in controlling 
mitochondrial Ca2+ uptake and metabolism, and 
intrinsic apoptosis, and myriad effects of Bcl-2 
family members on IP3R activity and ER Ca2+ 
content have been described [11,12,16].   Perhaps 
most significantly, it has been reported that Bcl-2 
promotes prosurvival Ca2+ signals, while inhibiting 
proapoptotic Ca2+ signals [17-20,11,12], and 
similar effects have been reported for Bcl-xL and 
Mcl-1 [19,21,11,12]; it remains controversial, 
however, whether this is due to a direct effect of 
Bcl-2 etc on the Ca2+ releasing properties of IP3Rs, 
or because they also reduce ER Ca2+ content 
[11,12,16].  Conversely, it has been reported that 
Bax and Bak increase ER Ca2+ content [22,23], and 
it has been proposed that this reflects the fact that 
Bcl-2 family members regulate IP3R 
phosphorylation and thus Ca2+ leak from the ER 
[11,16,22].   Physical interactions between anti-
apoptotic Bcl-2 family proteins and IP3Rs have 
been described [18-21], and, at least for Bcl-2, this 
is mediated by the BH4 domain [20,24-26].  In 
contrast, to date, there is no clear evidence for 
direct binding of pro-apoptotic proteins to IP3Rs 
[22,23,11].      
Here we report that Bok interacts robustly 
with IP3Rs, that this interaction is by far the 
strongest among the Bcl-2 family, that the binding 
site is in the coupling domain of IP3Rs adjacent to 
other regulatory sites, and that the most significant 
consequence of this binding appears to be 
protection of IP3Rs from proteolysis.   
 
EXPERIMENTAL PROCEDURES  
Materials — αT3 cells, HeLa cells, and HEK 293T 
cells were cultured as described [15,27,28]. SV40 
large T antigen-immortalized wild-type (C57BL/6) 
and Bok-/- (C57BL/6) mouse embryonic fibroblasts 
(MEFs) [8] were cultured in DMEM plus 5% fetal 
bovine serum and antibiotics (100 units penicillin 
and 100μg streptomycin/ml). Antibodies raised in 
rabbits were: anti-IP3R1, raised against amino 
acids 2731-2749 of IP3R1 [15]; anti-IP3R1326-341, a 
kind gift from Dr Suresh Joseph, Thomas Jefferson 
University, Philadelphia, PA; anti-IP3R11829-1848 
(Affinity Bioreagents, Inc.); anti-IP3R2 and anti-
IP3R3 [15]; anti-erlin2 [28]; anti-HA epitope [30]: 
anti-Mcl-1 D35A5, anti-Bcl-xL 54H6, anti-
caspase-3 9662 and anti-Bcl-2 50E3 (Cell 
Signaling Technology); anti-Bak 06-536 
(Millipore); anti-Bax N-20 (Santa Cruz 
Biotechnology Inc.); and anti-Bok, raised against 
amino acids 19-32 of mouse Bok [7,8].  Mouse 
monoclonal antibodies were: anti-IP3R3, raised 
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against amino acids 22-230 of human IP3R3 (BD 
Transduction Labs.); anti-ubiquitin clone FK2 
(BioMol International); anti-HA epitope clone 
HA11 (Covance), and anti-FLAG epitope clone 
M2 (Sigma). Rat monoclonal anti-IP3R1679-727 
clone 4C11 was a kind gift from Dr Katsuhiko 
Mikoshiba, RIKEN, Japan. Horse radish 
peroxidase-conjugated secondary antibodies, raised 
in goat, were obtained from Sigma.  Gonadotropin-
releasing hormone (GnRH), oleoyl-L-α-
lysophosphatidic acid (LPA), N-ethylmaleimide, 
ATP, IP3, protease inhibitors, Triton X-100, 
CHAPS, chymotrypsin type I-S and digitonin were 
purchased from Sigma. DTT, Precision PlusTM 
Protein Standards, and SDS-PAGE reagents were 
from Bio-Rad.  Protein A-Sepharose CL-4B was 
from Amersham Biosciences.  MG132 was from 
Biomol.  Staurosporine was from Enzo Life 
Sciences. 
Cell lysis, immunoprecipitation, SDS-PAGE, and 
mass spectrometry — To prepare cell lysates for 
SDS-PAGE or for immunoprecipitation, cells were 
harvested with ice-cold lysis buffer (150 mM 
NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% CHAPS 
or 1% Triton X-100, 10 μM pepstatin, 0.2 mM 
phenylmethylsulfonyl fluoride, and 0.2 μM 
soybean trypsin inhibitor, pH 8.0) usually 
supplemented with 1 mM DTT.  When IP3 receptor 
polyubiquitination was assessed in MEFs, cells 
were harvested with DTT-free lysis buffer, then 5 
mM N-ethylmaleimide was added to the lysates for 
30 min, followed by 5 mM DTT.  Lysates were 
incubated on ice for 30 min and clarified by 
centrifugation at 16,000 x g for 10 min at 4°C.  To 
immunoprecipitate specific proteins, clarified 
lysates were incubated with antisera and Protein A-
Sepharose CL-4B for 4-16 h at 4°C, and 
immunoprecipitates were washed thoroughly with 
lysis buffer, resuspended in gel-loading buffer 
[29], incubated at 37ºC for 30 min, subjected to 
SDS-PAGE, and either transferred to nitrocellulose 
for immunoblotting, or silver stained as described 
[30].   Immunoreactivity was detected and mass 
spectrometry was performed as described [30].    
Analysis of exogenous Bok and IP3Rs - A vector 
encoding mouse Bok tagged at the N-terminus 
with a triple FLAG epitope (3F-Bok) was created 
by inserting the mouse Bok cDNA sequence [8] 
into the KpnI / BamHI sites of p3xFLAG-CMV-10 
(Sigma).  This provided the template for the 
creation by PCR (primers available upon request) 
of vectors encoding 3F-Bok with N-terminal 
deletions and point mutations (Figure 4A). 
Likewise, a vector encoding mouse IP3R1 tagged 
at the C-terminus with an HA epitope [27] was the 
origin of N-terminal deletion mutants (Figure 4C).  
Vectors encoding IP3R1-3 have been described 
[31].  The authenticity of all cDNAs was 
confirmed by DNA sequencing.  HEK 293T cells 
seeded at 3-4 x 105 / 9.6cm2 well, were transfected 
~24h later with 1-2 μg cDNAs and 6-9μl Superfect 
(Qiagen), and ~24h later were harvested with ~ 
0.4ml/well 1% CHAPS lysis buffer.  Lysates were 
then incubated without or with anti-IP3R1, anti-
IP3R2, anti-IP3R3, anti-HA or anti-FLAG, and 
immunoprecipitates and input lysates were 
subjected to SDS-PAGE.   
Ca2+ mobilization - Cytosolic Ca2+ concentration 
([Ca2+]c) was measured essentially as described 
[29]. Cells were harvested with HBSE [29], 
centrifuged (500 x g for 5min), resuspended in 
DMEM, recentrifuged, and finally resuspended at 
2mg protein / ml in DMEM plus 10% fetal bovine 
serum and 10μM Fura 2-AM.  After 1h at 37°C, 
cells were centrifuged (500 x g for 1min), were 
washed once with KHB [29],  were resuspended in 
KHB at 1mg protein / ml and [Ca2+]c  was 
measured at room temperature [29].   To prepare 
permeabilized cells,  cells were harvested with 
HBSE, were centrifuged (1500 x g for 5min), were 
resuspended and incubated at 37°C for 10min in 
DMEM plus 10% fetal bovine serum, were 
recentrifuged, were resuspended in ice-cold cytosol 
buffer (120 mM KCl, 2 mM KH2PO4, 2 mM 
MgCl2, 2 mM ATP, 20 mM HEPES, pH 7.3), were 
recentrifuged, and finally were incubated at ~6mg 
protein / ml in cytosol buffer with 100μg/ml 
digitonin for 10min at 4°C.  The permeabilized 
cells were then centrifuged (2000 x g for 2min at 
4°C), were resuspended in cytosol buffer, 1μM 
Fura-2 was added and [Ca2+] in the suspension was 
measured [29].   
Data analysis — All experiments were repeated at 
least once (n = the number of independent 
experiments) and representative images of gels and 
traces are shown. Quantitated data are graphed as 
mean ±SEM. 
 
RESULTS 
Bok associates with IP3 receptors - Several 
proteins that regulate IP3Rs have been identified by 
co-immunoprecipitation; for example, 3 proteins 
 4
(erlin1, erlin2 and RNF170) that mediate the 
degradation of activated IP3Rs by the ubiquitin-
proteasome pathway (UPP) were discovered on the 
basis of their association with IP3R1 
immunoprecipitated from GnRH-stimulated αT3 
mouse pituitary cells [28,30,32-34].  Additional 
analysis of anti-IP3R1 immunoprecipitates from 
αT3 cells revealed the presence of a 23kDa co-
immunoprecipitating protein that was shown by 
mass spectral analysis to be Bok (Fig 1A).   
αT3 cells respond to GnRH with a robust 
increase in IP3 formation [35] and IP3R 
degradation by the UPP [27,28,32-35], mediated 
by the erlin1/2 complex and RNF170, which 
rapidly associate with activated IP3R1 [30,32-34].    
However, in contrast to erlin2, Bok co-
immunoprecipitation with IP3R1 was unaltered by 
acute exposure to GnRH, indicating that Bok is 
constitutively associated with IP3R1, irrespective 
of the activation state of IP3R1 (Fig 1B).  Since, in 
principle, the presence of Bok in anti-IP3R1 
immunoprecipitates could be an artifact of 
unanticipated cross-reactivity of Bok with anti-
IP3R1 (the epitope for which is amino acids 2731-
2749 of IP3R1), we also examined whether other 
antibodies raised against different IP3R1 epitopes 
could recover Bok.  This was indeed the case, as 
antibodies raised against amino acids 326-341 and 
1829-1848 of IP3R1 also efficiently recovered Bok 
(data not shown).   Furthermore, in MEFs, which 
express substantial amounts of both IP3R1 and 
IP3R3 (Figure 7), immunoprecipitation with either 
anti-IP3R1 or anti-IP3R3 recovered Bok (Fig 1C). 
Thus, Bok association with IP3Rs is not dependent 
upon how IP3Rs are immunoprecipitated and is 
seen in multiple cell types.   Interestingly, and 
somewhat surprisingly given the extensive 
literature on the topic [11,12,16-21,24-26], other 
members of the Bcl-2 family did not detectably co-
immunoprecipitate with IP3R1 (Figure 1D); this 
was the case for all of the family members 
examined, whether anti-apoptotic (Mcl-1, Bcl-2 
and Bcl-xL), or pro-apoptotic (Bak and Bax).   
Overall, these data indicate that among the Bcl-2 
family, Bok exhibits by far the strongest 
interaction with IP3Rs. 
The majority of Bok is IP3R-associated - In 
addition to demonstrating that Bok associates with 
IP3R1, the data in Fig 1D also suggest that a large 
proportion of cellular Bok is IP3R associated, since 
the relatively weak Bok signal seen in cell lysates 
is enhanced in IP3R1 immunoprecipitates to an 
extent similar to that seen for IP3R1.  The extent to 
which Bok is IP3R associated was more carefully 
assessed in αT3 cells, and also in HeLa cells and 
MEFs (Figure 2).  In all cell types anti-IP3R1 
recovered Bok, and interestingly HeLa cell Bok 
migrated as a single band at 22kDa, rather than as 
the doublet at 23/21kDa seen in αT3 cells and 
MEFs (upper panels, lanes 2, 4 and 6).  
Importantly, anti-IP3R1 depleted the vast majority 
of IP3R1 immunoreactivity from αT3 and HeLa 
cell lysates and caused a similar decrease in Bok 
immunoreactivity (lower panels, lanes 1-4), 
indicating that in these cell types most, and 
perhaps all, Bok is IP3R associated.  A similar 
situation exists in MEFs, in which IP3R 
immunoprecipitation was less efficient (for a 
reason that remains unclear), but in which IP3R1 
immunodepletion was again equivalent to that seen 
for Bok (lower panels, lanes 5 and 6).   
Bok binds preferentially to IP3R1 and IP3R2 - To 
examine whether Bok binds equally well or 
differentially to IP3R1, IP3R2 and IP3R3, HEK 
293T cells were co-transfected to express 3F-Bok 
and each receptor type, followed by assessment of 
interactions by co-immunoprecipitation (Figure 3).  
Previous studies have shown that exogenous IP3Rs 
are expressed at high levels in HEK 293T cells, 
such that the contribution of endogenous IP3Rs to 
biochemical measurements (e.g. IP3R 
phosphorylation) is negligible or undetectable [31].   
Immunoprecipitation of IP3R1 and IP3R2 
recovered a considerable amount of 3F-Bok 
(Figure 3A, lanes 2 and 4), while much less was 
recovered when IP3R3 was immunoprecipitated 
(lane 6).  Note that lane 6 also shows that Bok does 
not bind non-specifically to IgG (also shown in 
Figure 4D, lane 1). Importantly, conditions were 
arranged such that similar amounts of each 
receptor type were expressed and 
immunoprecipitated, as demonstrated by 
Coomassie staining of duplicate gels (Figure 3A, 
top panel).  Further, the observed interaction 
between IP3Rs and 3F-Bok represents a 
physiological phenomenon, rather than an event 
that occurs after cell lysis, since mixing lysates 
from cells expressing either IP3R1 or 3F-Bok did 
not result in co-immunoprecipitation of 3F-Bok 
(Figure 3B, lane 2).    The preferential binding of 
Bok to IP3R1 and IP3R2 was confirmed by 
immunoprecipitating 3F-Bok from the co-
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transfected cells (Figure 3C); this led to the 
recovery of a substantial amount of IP3R1 and 
IP3R2 (lanes 2 and 6), but much less IP3R3 (lane 
10).   Thus, Bok binds selectively to IP3R1 and 
IP3R2. 
Determinants of Bok-IP3R binding - To define the 
region of Bok that binds to IP3Rs, Bok was initially 
truncated from the N-terminus to remove specific 
regions (Figure 4A) and binding to IP3R1 was 
assessed by co-immunoprecipitation (Figure 4B).  
That 3F-BokΔ1-14 co-immunoprecipitates well, but 
3F-BokΔ1-45 does not (Figure 4B, lanes 3 and 4), 
indicates that the region between amino acids 15-
45 of Bok mediates binding to IP3Rs, and suggests 
that the putative BH4 domain might be 
responsible.  This notion was examined further 
with a mutant in which residues of the putative 
BH4 domain were replaced with alanine (Figure 
4A); that 3F-BokA34-38 does not co-
immunoprecipitate (Figure 4B, lane 6) provides 
additional evidence that the BH4 domain mediates 
binding to IP3Rs, although the possibility remains 
that deletion/disruption of the BH4 domain 
perturbs another region of Bok that is the true 
mediator of binding. 
 Conversely, to define the IP3R region that 
binds to Bok, IP3R1 was truncated from the N-
terminus to remove specific regions, guided by 
knowledge of the domain structure of IP3Rs  
[13,14,32] (Figure 4C).  That 3F-Bok co-
immunoprecipitates with IP3R1HAΔ1-1581 as well as 
it does with IP3R1HAWT (Figure 4D, lanes 3 and 
4), but not with IP3R1HAΔ1-2268 (lane 8), initially 
indicated that Bok binds between residues 1582-
2268 (i.e. to the C-terminal part of the coupling 
domain).   More subtle truncations were used to 
locate the exact binding site; 3F-Bok bound 
strongly to both IP3R1HAΔ1-1884 and IP3R1HAΔ1-1894 
(lanes 5 and 6), but not to IP3R1HAΔ1-1903 (lane 7), 
indicating that Bok binds between residues 1895-
1903 (amino acid sequence PSRKKAKEP).  
Interestingly, this highly charged sequence is 
completely conserved in IP3R1 from other species 
(e.g. rat and human), but not in IP3R2 and IP3R3.   
However, a sequence with a very similar charge 
distribution is found in the corresponding region of 
IP3R2 (PRMRVRDS), and is completely conserved 
in mouse, rat and human.    
The significance of Bok binding to IP3Rs 
To examine the significance of the Bok-
IP3R interaction, we initially compared the 
properties of SV40 large T antigen-immortalized 
wild-type (WT) and Bok-/- MEFs.     Analysis of 
lysates showed that the absence of Bok did not 
alter the levels of other Bcl-2 family proteins 
(Figure 5A), and analysis anti-IP3R1 
immunoprecipitates showed that the absence of 
Bok did not facilitate the binding of other Bcl-2 
family proteins to IP3R1 (Figure 5B).  
Interestingly, however, IP3R levels were altered by 
the absence of Bok, with IP3R1 levels increasing, 
and IP3R2 and IP3R3 levels decreasing (Figure 5A; 
also see Figure 7A).     
Examination of [Ca2+]c showed that LPA, 
which has previously been reported to stimulate 
IP3 formation in fibroblasts [36],  induced 
essentially identical responses in WT and Bok-/- 
MEFs (Figure 6A).  In these experiments, EGTA 
was added just prior to LPA to chelate extracellular 
Ca2+ and block Ca2+ entry [37], such that changes 
in [Ca2+]c are a measure of the release of 
intracellular Ca2+ stores.  Thus, Bok does not 
appear to regulate IP3R-mediated Ca2+ store release 
in intact cells under these conditions.   To more 
directly assess IP3R function, IP3-induced Ca2+ 
mobilization was assessed in suspensions of 
permeabilized cells, in which exogenous IP3 can 
gain access to IP3Rs and release ER Ca2+ stores.  
Again, however, Ca2+ mobilization was the same in 
WT and Bok-/- MEFs (Figure 6B), indicating that 
the Ca2+ mobilizing function of IP3Rs is not 
governed by Bok.   Further, re-uptake of the Ca2+ 
released by IP3 was identical in WT and Bok-/- 
MEFs, indicating that ER Ca2+ storage is also not 
regulated by Bok (Figure 6B).    
 Prolonged activation of IP3Rs triggers 
their down-regulation by the UPP; they are first 
polyubiquitinated, and then transferred to the 
proteasome for degradation [32,33,38].  To 
examine whether these events are influenced by 
Bok, MEFs were exposed to LPA, and IP3R levels 
were monitored.  LPA caused a decline in IP3R1-3 
levels in WT MEFs in a manner that was partially 
blocked by the proteasome inhibitor MG132 
(Figure 7A, lanes 1-6), indicating that IP3Rs are 
down-regulated by the UPP under these conditions 
[27,32].  However, very similar down-regulation 
was seen in Bok-/- MEFs (lanes 7-12), indicating 
that Bok is not required for this process (this was 
true for IP3R1 and IP3R3, whereas IP3R2 was 
undetectable).  Consistent with this conclusion, 
IP3R polyubiquitination, the other hallmark of IP3R 
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processing by the UPP [27,32], was not inhibited 
by the absence of Bok (Figure 7B).  In fact, IP3R 
polyubiquitination was slightly greater in the Bok-/- 
MEFs, but this is most likely due to the increased 
expression of IP3R1 and its presence in 
immunoprecipitates (compare lanes 4 vs. 2, and 8 
vs. 6). 
Interestingly, Bok expression was reduced 
in parallel to IP3Rs expression in stimulated cells.  
This was apparent in LPA-stimulated WT MEFs 
and, again, was partially blocked by MG132 
(Figure 7A, lanes 1-6), suggesting that it is via the 
UPP.   Additional experiments with αT3 cells 
confirmed that Bok down-regulation occurs as 
IP3R levels decline (Figure 7C, upper two panels), 
and also that as Bok levels decline, the amounts of 
other Bcl-2 family proteins and erlin2 are 
unaffected (lower panels).   Analysis of the time-
dependence of GnRH effects showed that IP3R1 
and Bok decline at similar rates, and, again, that 
MG132 partially blocks the declines (Figure 7D).    
Further, GnRH induced the formation of high 
molecular mass Bok immunoreactivity (e.g. at 26-
27kDa) that was enhanced by MG132, suggesting 
that Bok might be ubiquitinated (Figure 7D, lane 2 
and lanes 7-10).  Further evidence that Bok is 
ubiquitinated in stimulated αT3 cells came from 
analysis of anti-IP3R1 immunoprecipitates (Figure 
7E).  As expected, Bok co-immunoprecipitates 
strongly with IP3R1 (lanes 4 and 5), and the high 
molecular mass anti-Bok immunoreactive bands 
seen in the presence of GnRH at 26-27kDa and 
above (lane 5), were also found to be anti-ubiquitin 
immunoreactive (lane 2).   This selective 
ubiquitination and down-regulation of Bok and 
IP3Rs, together with the finding that a large 
proportion of cellular Bok is IP3R associated, 
suggests that they may be processed by the UPP as 
a combined unit. 
Finally, we examined whether Bok might 
regulate IP3R1 proteolysis, since its binding site is 
adjacent to the site cleaved by caspase-3 during 
apoptosis [13,39,40] and to one of the 
chymotrypsin-sensitive sites that is thought to be a 
flexible, exposed loop [13,32,41,42]  (Figure 4C).   
Interestingly, we found that Bok markedly 
inhibited chymotrypsin-induced IP3R1 proteolysis 
in vitro, as gauged by the production of fragments 
IV and V (Figure 8).  Exposure of IP3R1 
immunopurified from transfected cells to 
chymotrypsin generated free fragments V and IV 
at ~90 and ~40kDa, respectively (Figure 8A, lanes 
2 and 6), and this was almost completely blocked 
when 3F-Bok was co-expressed with IP3R1 (lanes 
4 and 8).  Instead, an ~130kDa fragment was 
formed that was recognized by both fragment IV- 
and V-specific antisera, and thus appears to be a 
cleavage product composed of fragments IV+V 
(lanes 4 and 8). An analogous result was obtained 
when IP3R1 was immunopurified from WT and 
Bok-/- MEFs; in this case, the generation of free 
fragments V and IV was much more efficient for 
material immunopurified from Bok-/- MEFs 
(Figure 8B, lanes 4 and 8), than for material 
immuopurified from WT MEFs, in which a band 
corresponding to fragments IV+V was again 
observed (lanes 2 and 6).  Remarkably, then, it 
appears that the association of Bok with IP3Rs 
inhibits chymotrypsin-induced cleavage at the 
fragment IV-V junction.   
We also examined the sensitivity of IP3R1 
to caspase-3, by monitoring IP3R1 cleavage in cells 
undergoing apoptosis (Figure 8C).  In response to 
the kinase inhibitor staurosporine and other pro-
apoptotic agents, caspase-3 is activated and IP3R1 
is cleaved into two major fragments, a C-terminal, 
~95kDa fragment that may form “leaky” channels, 
and an ~170kDa fragment that accounts for the 
remainder of the protein [39,40,43,44].   In the 
presence of staurosporine, both of these fragments 
were much more readily visible in Bok-/- MEFs 
than in WT MEFs, while caspase-3 activation was 
approximately the same in both cell types (Figure 
8C, lanes 3 and 4).   Thus, Bok appears to protect 
IP3R1 from the proteolytic activity of caspase-3. 
Overall, these data indicate that despite 
binding strongly to IP3Rs and regulating their 
expression, Bok does not appear to regulate the 
Ca2+ gating function of IP3Rs, or the ability of 
IP3Rs to be degraded by the UPP.  However, Bok 
is selectively degraded by the UPP in parallel to 
IP3Rs and, most importantly, protects IP3Rs from 
the proteolytic effects of chymotrypsin in vitro and 
caspase-3 in vivo during apoptosis. 
 
DISCUSSION 
 In summary, we find (i) that Bok binds 
constitutively to IP3Rs, (ii) that the determinants of 
binding appear to be the BH4 domain of Bok and a 
small peptide in a highly-regulated region of the 
coupling domain of IP3Rs, (iii) that the binding of 
Bok does not seem to regulate the Ca2+ mobilizing 
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function of the channels formed by IP3Rs, (iii) that 
Bok is degraded by the UPP in parallel to the 
degradation of IP3Rs that occurs when IP3-
dependent cell signaling is persistently activated, 
and, most importantly, (iv) that Bok protects IP3Rs 
from proteolysis in vitro and in vivo during 
apoptosis.   Overall, these data show that Bok is 
tightly associated with IP3Rs and that one of its 
cellular roles is to control IP3R proteolysis. 
 The strength of Bok binding to IP3Rs is 
surprising.  Clear co-immunoprecipitation of Bok 
with IP3Rs was seen using either CHAPS or Triton 
X-100 as detergents, and remarkably, most, if not 
all, cellular Bok was found to be IP3R bound, since 
Bok was immunodepleted in parallel to IP3Rs 
when IP3Rs were immunoprecipitated.  Further, 
under conditions that allowed for robust Bok 
binding, the binding of other Bcl-2 family proteins 
was not detectable.   This is perplexing in view of 
the extensive literature indicating that anti-
apoptotic Bcl-2 family members bind to IP3Rs 
[11,12,16-21,24-26].  However, evaluation of that 
literature suggests only relatively weak binding of 
endogenous pro-apoptotic Bcl-2 family members 
to endogenous IP3Rs [18,21,22,45,46], and reveals 
that many of the studies were conducted with over-
expressed proteins, or with purified recombinant 
protein fragments [18-21,24,26], which may not 
faithfully mimic physiological interactions.    Such 
relatively weak binding may be beyond the limits 
of detection under the experimental conditions 
used herein, which were geared towards the 
assessment of the particularly strong Bok-IP3R 
interaction.    
 Our studies with Bok and IP3R mutants 
indicate that the putative BH4 domain of Bok 
[3,47] mediates binding to IP3Rs and that the Bok 
binding site is located within a small sequence 
(PSRKKAKEP) found in a highly-regulated region 
of IP3Rs, that is likely a surface-exposed loop 
[32,33,41].  Interestingly, the BH4 domain of Bcl-
2 also appears to mediate its binding to IP3Rs 
[20,24-26], although the Bcl-2 binding site is 
located within a completely different IP3R region 
(amino acids 1389-1408 of IP3R1) [25,26]. It has 
also been shown that the BH4 domain of Bcl-xL 
binds much more weakly to IP3Rs than does the 
Bcl-2 BH4 domain, because it contains an aspartic 
acid residue instead of a lysine at position X2 of the 
BH4 consensus sequence [20] (Figure 4A).  
Overall, this information indicates that the BH4 
domain of Bok and some other Bcl-2 family 
proteins is critical for mediating binding to IP3Rs, 
but that different modes of interaction are possible.   
Since Bax and Bak also contain a very similar 
putative BH4 domain (Figure 4A), it is puzzling 
that they too do not bind to IP3Rs.  The explanation 
may be that Bok is more localized to the ER and 
Golgi than Bax and Bak, apparently because of 
differences in their TM regions [8].  This would 
place Bok in the proximity of IP3R receptors, 
which are also predominantly localized to the ER 
[13,14], but are also present in the Golgi [48]. 
 The nature of the Bok binding region in 
IP3R1 is intriguing.  It is obvious that the sequence 
is highly polar (5 of 9 residues are charged), and it 
is tempting to speculate that this could drive the 
interaction with the Bok BH4 domain, which also 
contains charged residues (Figure 4A).  A similar 
sequence is found in the corresponding region of 
IP3R2 (4 of 8 residues are charged), but no such 
charge density is found in the corresponding region 
of IP3R3, which is very different from IP3R1 and 
IP3R2 in this area.   This diversity may well 
account for the ability of Bok to bind strongly to 
IP3R1 and IP3R2, but not to IP3R3.    
 The challenge now is to determine the 
significance of the Bok-IP3R interaction.  The data 
from MEFs, either replete with or lacking Bok, 
indicate that Bok does not regulate the ability of 
IP3Rs to act as Ca2+ channels, or the ability of the 
ER to sequester Ca2+, at least in unperturbed cells.  
Further, the processing of activated IP3Rs by the 
UPP was not dependent upon the presence of Bok, 
indicating that it does not play a role in this 
homeostatic phenomenon [32,33].  Bok did, 
however, regulate IP3R expression.  This was seen 
in MEFs, in which lack of Bok increased IP3R1 
expression, but decreased IP3R2 and IP3R3 
expression.  Effects of exogenous Bcl-2 family 
proteins on IP3R expression have been seen in 
other cell types [46,49], although not always [45]. 
While the basis for these expression changes 
remains to be defined, overall our results indicate 
that Bok is not critical to the central function of 
IP3Rs, which is to act as IP3-gated Ca2+ channels.    
Interestingly, in cells in which IP3-
dependent signaling was persistently activated, 
Bok was degraded by the UPP, while the levels of 
other Bcl-2 family protein remained unaltered.   It 
is well known that IP3Rs are degraded by the UPP 
under these conditions [32,33] and the finding that 
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Bok is degraded in parallel is consistent with the 
notion that endogenous Bok and IP3Rs are 
constitutively associated.  Bok and IP3Rs may well 
be extracted from the ER membrane, ubiquitinated 
and degraded as a unit [38], and it will be 
interesting to see whether the proteins that mediate 
IP3R ubiquitination (the erlin1/2 complex and the 
ubiquitin ligase RNF170 [30,34]) also mediate Bok 
ubiquitination.   IP3R degradation by the UPP is 
seen to be a homeostatic response to persistent cell 
stimulation that allows cells to reduce the 
sensitivity of their Ca2+ stores to IP3 and thus 
suppress Ca2+ mobilization [32,33].   That Bok 
should be degraded in parallel is currently of 
unknown significance, but given that Bok is 
generally considered to be pro-apoptotic, loss of 
Bok could well influence the viability of the 
stimulated cells. 
 The most significant effect of Bok binding 
appears to be inhibition of IP3R proteolysis by 
chymotrypsin in vitro at the fragment IV-V 
junction (at amino acid ~1932), and by caspase-3 
in vivo during apoptosis (at amino acid 1891).    It 
seems entirely plausible that this could result from 
steric hindrance by Bok of the ability of 
chymotrypsin and caspase-3 to access their 
cleavage sites.  This inhibitory effect of Bok may 
well be biologically relevant, as the C-terminal 
IP3R1 fragment resulting from caspase-3 cleavage 
has been proposed to form an IP3-insensitive, 
“leaky” channel that contributes towards the 
apoptotic cascade [40,43], although this notion is 
controversial [44,50,51].  Indeed, a very recent 
study shows that the IP3R1 fragments generated by 
caspase-3 remain associated and form functional 
channels fully capable of responding to IP3 and 
contributing towards apoptosis [44]. Thus, the 
significance of the inhibitory effect of Bok on IP3R 
proteolysis will be better understood when the 
significance of IP3R cleavage by caspase-3 is fully 
elucidated.  
The cellular role of Bok has been an 
enigma since its discovery [1,2,7]. Based on its 
similarity to Bax and Bak and over-expression 
studies, it has been assumed that Bok is pro-
apoptotic [4-9] and, indeed, very recent evidence 
from Bax-/- Bok-/- mice indicates that it can act pro-
apoptotically in ovaries [52].   Interestingly, 
however, Bok can also act anti-apoptotically; Bok-
/- cells undergo apoptosis more readily than control 
cells in response to brefeldin A, a drug that inhibits 
ER to Golgi transport and causes ER stress [8]. 
Determining the role played by IP3R binding in 
these effects of Bok will be a fascinating topic for 
future studies and should help unravel the 
subtleties of Bok action.   
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FIGURE LEGENDS 
 
Figure 1. Bok co-immunoprecipitates with IP3Rs    Cells were harvested with 1% CHAPS lysis buffer, 
and immunoprecipitates were prepared and subjected to SDS-PAGE (n=2). A) The 20-25kDa region of a 
silver-stained gel of an anti-IP3R1 immunoprecipitate from αT3 cells is shown and the 23 kDa band 
marked with an arrow was identified by mass spectrometry as Bok.   B) αT3 cells were treated for the 
indicated times with 100nM GnRH, and anti-IP3R1 immunoprecipitates (lanes 2-4) and controls (lanes 1 
and 5) were probed in immunoblots for IP3R1, erlin2 and Bok.  C)  Using MEFs, anti-IP3R1 and anti-
IP3R3 immunoprecipitates (lanes 2 and 3), and a control (lane 1) were probed in immunoblots for IP3R1, 
IP3R3, erlin2 (negative control) and Bok.  Note that because of IP3R heterotetramerization [13,15], anti-
IP3R1 recovers some IP3R3, and anti-IP3R3 recovers some IP3R1.   Mouse monoclonal anti-IP3R3 was 
used for these experiments.  D)  Using αT3 cells, anti-IP3R1 immunoprecipitates and input cell lysates 
were probed in immunoblots for the proteins indicated. 
 
Figure 2. Immunodepletion of IP3R1 causes equivalent immunodepletion of Bok.    Cells were harvested 
with 1% CHAPS lysis buffer, lysates were incubated without or with anti-IP3R1, and immunoprecipitates 
and post-immunoprecipitation lysates were subjected to SDS-PAGE.  Immunoblots were then probed for 
IP3R1 and Bok, and for erlin2, which served as a loading control for cell lysates (n=2).  
 
Figure 3. Bok binds selectively to IP3R1 and IP3R2 
HEK 293T cells were transfected with cDNAs encoding 3F-Bok and/or each IP3R type and 24h later were 
harvested with 1% CHAPS lysis buffer, lysates were incubated with anti-IP3R1, anti-IP3R2, anti-IP3R3, or 
anti-FLAG, and immunoprecipitates and input lysates were subjected to SDS-PAGE (n=3).  Gels were 
then either stained with Coomassie blue, or immunoblots were probed for IP3R1-3 (with anti-IP3R1-3) or 
3F-Bok (with anti-FLAG).  A.  Assessment of 3F-Bok binding to immunoprecipitated IP3R1, IP3R2 and 
IP3R3.  B.  Demonstration that 3F-Bok and IP3R1 do not co-immunoprecipitate when lysates from cells 
expressing either IP3R1 or 3F-Bok are mixed and then incubated with anti-IP3R1 to immunoprecipitate 
IP3R1.    C.  Assessment of IP3R binding to immunoprecipitated 3F-Bok.     
 
Figure 4.  Analysis of the determinants of Bok-IP3R binding 
A. 3F-Bok constructs used to map the region that binds to IP3Rs.  Shown are the N-terminal triple FLAG 
tag (grey box), the position of the BH1-4 domains [5,6], the transmembrane (TM) region, and the 
sequence of the putative BH4 domain of mouse Bok, together with that for Bcl-2, Bcl-xl, Bax and Bak.  
These approximate to the consensus sequence Ф1Ф2X1X2Ф3Ф4, where X is any residue, Ф is a 
hydrophobic residue, and Ф3 is an aromatic residue [3,47].   Also shown is the point mutant used to 
further resolve the binding site.  B. HEK 293T cells were transfected with cDNAs encoding 3F-Bok 
constructs and IP3R1, and 24h later were harvested with 1% CHAPS lysis buffer, lysates were incubated 
without or with anti-IP3R1, immunoprecipitates and input lysates were subjected to SDS-PAGE, and 
immunoblots were probed for IP3R1 or the 3F-Bok constructs (n=3).  C. IP3R1HA constructs used to map 
the region that binds to Bok.  Shown are the C-terminal HA tag (thick black line), the positions of the 3 
functional domains (the ligand-binding domain, the coupling domain, and the channel domain) 
[13,14,32], two of the sites (at ~1583 and ~1932) susceptible to proteolysis by chymotrypsin (CT) and 
two of the proteolytic fragments (IV and V) [13,32,41,42], and the caspase-3 cleavage site (at 1891) 
[13,39,40].  Numbering is according to the mouse sequence.  D. HEK 293T cells were transfected with 
cDNAs encoding IP3R1HA constructs and 3F-Bok, and 24h later were harvested with 1% CHAPS lysis 
buffer, lysates were incubated without or with rabbit polyclonal anti-HA, immunoprecipitates and input 
lysates were subjected to SDS-PAGE, and immunoblots were probed for 3F-Bok or the IP3R1HA 
constructs with mouse monoclonal anti-FLAG or anti-HA (n=3). 
 
Figure 5.  Bcl-2 family members in WT and Bok-/- MEFs 
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Cells were harvested with 1% Triton lysis buffer, lysates (A) and anti-IP3R1 immunoprecipitates (B) were 
prepared, samples were subjected to SDS-PAGE, and immunoblots were probed for the proteins indicated 
(n=3).  Additional probing of immunoprecipitates did not reveal any binding of Bcl-xL, Bcl-2 or Bak to 
IP3R1 in WT or Bok-/- MEFs (data not shown)   
 
Figure 6.  Ca2+ signaling in WT and Bok-/- MEFs 
A. Cells in suspension were loaded with Fura 2, were exposed to 1μM LPA (arrow) and [Ca2+]c was 
calculated from the 340/380 nm fluorescence ratio.  EGTA (3mM) was added 1min prior to LPA to 
reduce extracellular [Ca2+] to ~100nM [37] and eliminate Ca2+ entry (n>10).   B.  Suspensions of 
permeabilized cells were exposed to increasing IP3 concentrations in the presence of Fura-2, and [Ca2+] 
was calculated from the 340/380 nm fluorescence ratio (n=2).  
 
Figure 7.  Degradation of IP3Rs and Bok by the UPP in MEFs and αT3 cells  
A. MEFs were incubated with 10μM LPA and 10μM MG132 for the times indicated, were harvested with 
1% Triton lysis buffer, lysates were prepared, samples were subjected to SDS-PAGE, and immunoblots 
were probed with anti-IP3R1-3 and anti-Bok as indicated.  The histograms show combined quantitated 
IP3R1-3 and Bok immunoreactivity normalized to WT t=0 values from multiple independent experiments 
(n≥3).   B.  MEFs were incubated without or with 10μM LPA for 50min, in the absence or presence of 
10μM MG132 (which was added 10min prior to LPA), were harvested with 1% Triton lysis buffer, anti-
IP3R1 immunoprecipitates were prepared, samples were subjected to SDS-PAGE, and immunoblots were 
probed with anti-ubiquitin, anti-IP3R1 and anti-Bok as indicated (n=2).  C.  αT3 cells were incubated 
without or with 1μM GnRH for 2h, were harvested with 1% CHAPS lysis buffer, lysates were prepared, 
samples were subjected to SDS-PAGE, and immunoblots were probed for the proteins indicated (n=2).  
D. αT3 cells were incubated with 1μM GnRH for the times indicated in the absence or presence of 
MG132 (which was added 30min prior to GnRH), and were processed as in C. The histograms show 
combined quantitated IP3R1 or Bok immunoreactivity from multiple independent experiments (n=3).   E.  
αT3 cells were incubated without or with 1μM GnRH for 15min, in the presence of 10μM MG132 (which 
was added 30min prior to GnRH), were harvested with 1% CHAPS lysis buffer, anti-IP3R1 
immunoprecipitates were prepared, samples and controls (lanes 3 and 6) were subjected to SDS-PAGE, 
and immunoblots were probed with anti-ubiquitin and anti-Bok as indicated (n=2). 
 
Figure 8.  Effects of Bok on IP3R1 proteolysis.  
A and B.  Anti-IP3R1 immunoprecipitates, prepared from transfected HEK 293T cells or MEFs with 1% 
CHAPS lysis buffer, were washed with ice-cold PBS, were incubated with 1μg/ml chymotrypsin (CT) for 
15 minutes at 25°C, were boiled for 5 minutes in gel-loading buffer [29], samples were subjected to SDS-
PAGE, and immunoblots were probed for fragment V with anti-IP3R12731-2749 and fragment IV with anti-
IP3R11829-1848 (n=2).   IP3R1-derived immunoreactive bands are indicated with arrows, as is cross-reacting 
IgG heavy chain at ~50kDa, and a probable IgG-derived fragment at ~35kDa.  C. Cells were incubated 
with 1μM staurosporine (SST) for 14h, were harvested with 1% Triton lysis buffer, lysates were subjected 
to SDS-PAGE, and immunoblots were probed with anti-IP3R12731-2749 and anti-IP3R1679-727 to detect C- and 
N-terminal IP3R1 fragments, respectively, and for the other proteins indicated.  Erlin2 served as a loading 
control (n=2).  
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